DE2853480C2 - - Google Patents
Info
- Publication number
- DE2853480C2 DE2853480C2 DE19782853480 DE2853480T DE2853480C2 DE 2853480 C2 DE2853480 C2 DE 2853480C2 DE 19782853480 DE19782853480 DE 19782853480 DE 2853480 T DE2853480 T DE 2853480T DE 2853480 C2 DE2853480 C2 DE 2853480C2
- Authority
- DE
- Germany
- Prior art keywords
- magnetic
- active substance
- polymer particles
- biologically active
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920000642 polymer Polymers 0.000 claims description 50
- 239000002245 particle Substances 0.000 claims description 41
- 229940088623 biologically active substance Drugs 0.000 claims description 19
- 239000000696 magnetic material Substances 0.000 claims description 16
- 239000013543 active substance Substances 0.000 claims description 13
- 239000000126 substance Substances 0.000 claims description 11
- 229910000859 α-Fe Inorganic materials 0.000 claims description 11
- 239000011148 porous material Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 108091005804 Peptidases Proteins 0.000 claims description 3
- 102000035195 Peptidases Human genes 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- 239000003112 inhibitor Substances 0.000 description 8
- 239000000969 carrier Substances 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 238000003825 pressing Methods 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000011554 ferrofluid Substances 0.000 description 3
- 239000006249 magnetic particle Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000008100 Human Serum Albumin Human genes 0.000 description 2
- 108091006905 Human Serum Albumin Proteins 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- AEOBEOJCBAYXBA-UHFFFAOYSA-N A2P5P Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1OP(O)(O)=O AEOBEOJCBAYXBA-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 230000005653 Brownian motion process Effects 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000005537 brownian motion Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 230000001085 cytostatic effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2446/00—Magnetic particle immunoreagent carriers
- G01N2446/10—Magnetic particle immunoreagent carriers the magnetic material being used to coat a pre-existing polymer particle but not being present in the particle core
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE7706431A SE431214B (sv) | 1977-06-02 | 1977-06-02 | Sett att framstella magnetiska polymerpartiklar som berare av en foretredesvis biologiskt aktiv substans |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2853480T1 DE2853480T1 (en, 2012) | 1980-12-11 |
| DE2853480C2 true DE2853480C2 (en, 2012) | 1987-08-06 |
Family
ID=20331500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19782853480 Expired DE2853480C2 (en, 2012) | 1977-06-02 | 1978-06-01 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0007932B1 (en, 2012) |
| JP (1) | JPS5417110A (en, 2012) |
| DE (1) | DE2853480C2 (en, 2012) |
| GB (1) | GB2035798B (en, 2012) |
| SE (2) | SE431214B (en, 2012) |
| WO (1) | WO1978000005A1 (en, 2012) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2024007B (en) * | 1978-06-30 | 1983-04-27 | Gordon R T | Cancer-treating composition containing inductively heatable particles |
| US4297337A (en) * | 1979-04-13 | 1981-10-27 | Corning Glass Works | Solid-phase immunoassays using magnetic glass |
| US4331654A (en) * | 1980-06-13 | 1982-05-25 | Eli Lilly And Company | Magnetically-localizable, biodegradable lipid microspheres |
| JPS6336171Y2 (en, 2012) * | 1981-03-12 | 1988-09-26 | ||
| JPS57204318A (en) * | 1981-06-06 | 1982-12-15 | Aisin Seiki Co Ltd | Clutch disc |
| EP0093757A1 (en) * | 1981-11-12 | 1983-11-16 | Ulf SCHRÖDER | Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof |
| DE3227809A1 (de) * | 1982-07-24 | 1984-01-26 | LuK Lamellen und Kupplungsbau GmbH, 7580 Bühl | Drehschwingungsdaempfer, insbesondere fuer mit drehmomentenwandlern ausgeruestete kraftfahrzeugantriebe |
| DE3230664A1 (de) * | 1982-08-18 | 1984-02-23 | Fichtel & Sachs Ag, 8720 Schweinfurt | Torsionsschwingungsdaempfer mit axialer steuerblech-abstuetzung |
| JPS59140923A (ja) * | 1983-01-31 | 1984-08-13 | Atsugi Motor Parts Co Ltd | クラッチディスク |
| US5720939A (en) * | 1985-08-15 | 1998-02-24 | Nycomed Imaging As | Method of contrast enhanced magnetic resonance imaging using magnetically responsive-particles |
| US5618514A (en) * | 1983-12-21 | 1997-04-08 | Nycomed Imaging As | Diagnostic and contrast agent |
| GB8408127D0 (en) * | 1984-03-29 | 1984-05-10 | Nyegaard & Co As | Contrast agents |
| JPS6124533U (ja) * | 1984-07-19 | 1986-02-13 | 株式会社 大金製作所 | ダンパ−デイスク |
| JPS6152422A (ja) * | 1984-08-21 | 1986-03-15 | Mitsubishi Motors Corp | ダンパ−デイスク |
| EP0184899B1 (en) * | 1984-11-01 | 1990-04-18 | Nycomed As | Paramagnetic contrast agents for use in "in vivo" diagnostic methods using nmr, and their preparation |
| SE465907B (sv) * | 1984-11-01 | 1991-11-18 | Nyegaard & Co As | Diagnosticeringsmedel innehaallande en paramagnetisk metall |
| JPS61117923U (en, 2012) * | 1985-01-11 | 1986-07-25 | ||
| US4795698A (en) * | 1985-10-04 | 1989-01-03 | Immunicon Corporation | Magnetic-polymer particles |
| CS255758B1 (en) * | 1985-12-11 | 1988-03-15 | Frantisek Rypacek | Preparat for the diagnostic of transportion function of oviduct and process for preparing thereof |
| US4951675A (en) * | 1986-07-03 | 1990-08-28 | Advanced Magnetics, Incorporated | Biodegradable superparamagnetic metal oxides as contrast agents for MR imaging |
| US4770183A (en) * | 1986-07-03 | 1988-09-13 | Advanced Magnetics Incorporated | Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents |
| DE3709851A1 (de) * | 1987-03-24 | 1988-10-06 | Silica Gel Gmbh Adsorptions Te | Nmr-diagnostische fluessigkeitszusammensetzungen |
| CA1334936C (en) * | 1988-04-01 | 1995-03-28 | Walter Whitson-Fischman | Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration |
| US5162037A (en) * | 1988-04-01 | 1992-11-10 | Whitson Laboratories, Inc. | Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration |
| SU1722256A3 (ru) * | 1989-11-02 | 1992-03-23 | Viktor A Volkonskij | Cпocoб пoлучehия maгhиtoупpabляemoй диcпepcии |
| FR2656317B1 (fr) * | 1989-12-27 | 1994-02-04 | Rhone Poulenc Chimie | Microspheres magnetisables a base de polysilsesquioxane, leur procede de preparation et leur application en biologie. |
| EP0963832B1 (en) * | 1997-02-28 | 2002-09-25 | Idemitsu Petrochemical Co., Ltd. | Soft transparent polyethylene resin sheet |
| EP1306128A1 (en) * | 2001-10-29 | 2003-05-02 | Tenaxis Gmbh | Sorptive composite materials |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1467974A1 (de) * | 1964-06-08 | 1969-01-23 | Tsukamoto Kenkichi | Verfahren zur Verbesserung der Wirksamkeit von Eisenpraeparaten und Vorrichtung zur Durchfuehrung des Verfahrens |
| US3592185A (en) * | 1967-04-18 | 1971-07-13 | Yeda Res & Dev | Ferromagnetic contrast media and method of use |
| US3700555A (en) * | 1970-10-12 | 1972-10-24 | Technicon Instr | Method and apparatus for lymphocyte separation from blood |
| US3709791A (en) * | 1971-04-13 | 1973-01-09 | Technicon Instr | Method and apparatus for lymphocyte separation from blood |
| US4018886A (en) * | 1975-07-01 | 1977-04-19 | General Electric Company | Diagnostic method and device employing protein-coated magnetic particles |
| FR2334106A1 (fr) * | 1975-12-02 | 1977-07-01 | Pasteur Institut | Gel magnetique convenant pour dosages immunoenzymatiques |
-
1977
- 1977-06-02 SE SE7706431A patent/SE431214B/xx not_active IP Right Cessation
-
1978
- 1978-06-01 WO PCT/SE1978/000001 patent/WO1978000005A1/en unknown
- 1978-06-01 GB GB7903109A patent/GB2035798B/en not_active Expired
- 1978-06-01 DE DE19782853480 patent/DE2853480C2/de not_active Expired
- 1978-06-02 JP JP6660178A patent/JPS5417110A/ja active Granted
- 1978-12-08 EP EP78900004A patent/EP0007932B1/en not_active Expired
-
1979
- 1979-01-26 SE SE7900712A patent/SE441802B/sv not_active IP Right Cessation
Non-Patent Citations (1)
| Title |
|---|
| MOSBACH: Methods in Enzymology, Vol. XLIV, 1976, S. 201 ff, 216, 278-279, 324-325 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP0007932B1 (en) | 1983-08-24 |
| SE431214B (sv) | 1984-01-23 |
| GB2035798B (en) | 1982-11-03 |
| GB2035798A (en) | 1980-06-25 |
| JPS6360726B2 (en, 2012) | 1988-11-25 |
| EP0007932A1 (en) | 1980-02-20 |
| SE7706431L (sv) | 1978-12-03 |
| WO1978000005A1 (en) | 1978-12-07 |
| JPS5417110A (en) | 1979-02-08 |
| SE441802B (sv) | 1985-11-11 |
| DE2853480T1 (en, 2012) | 1980-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2853480C2 (en, 2012) | ||
| US4335094A (en) | Magnetic polymer particles | |
| DE3382834T3 (de) | Sorbentmittel und dessen Herstellungsverfahren | |
| DE2633259C3 (de) | Verfahren zum Unbeweglichmachen von Enzymen oder enzymhaltigen Zellen | |
| DE3519011A1 (de) | Verfahren zur herstellung eines materials zur affinitaetschromatographie | |
| EP1326708B1 (de) | Adsorbens mit unterschiedlich modifizierten oberflächenbereichen, verfahren zu dessen herstellung und verwendung davon | |
| DE1908290B2 (de) | Acrylamid-mischpolymerisat | |
| DE3039566A1 (de) | Verfahren zur reinigung von interferon | |
| DE2339238B2 (de) | Enzyme und/oder mikroorganismen in loesung oder dispersion enthaltender hohlfaden und verfahren zu seiner herstellung | |
| DE3407814A1 (de) | Phasentraeger fuer die verteilungschromatographie von makromolekuelen, verfahren zu ihrer herstellung und ihre verwendung | |
| DE2832536A1 (de) | Kuenstliches medizinisches material mit gerinnungshemmender wirkung | |
| DE2723454C3 (de) | Beständiger Komplex aus Träger und Aminoacylase | |
| DE69224517T2 (de) | Trägermaterial und biokompatibler Anionenanstauscher | |
| DE69621597T2 (de) | Adsorbens für tumornekrosefaktor alpha, methode zur entfernung durch adsorption und adsorptionsvorrichtung unter verwendung des adsorbens | |
| DE2924744A1 (de) | Verfahren zur reindarstellung von urokinase | |
| DE10011481A1 (de) | Adsorbens zum Absenken der Konzentration von Fibrinogen und/oder Fibrin, Verwendung des Adsorbens zur Herstellung eines Adsorbers und Adsorber mit dem Adsorbens | |
| DE10011482B4 (de) | Verfahren zum Herstellen eines Adsorbens zum Absenken der Konzentration von Fibrinogen und/oder Fibrin, Adsorbens und Verwendung des Adsorbens zur Herstellung eines Adsorbers | |
| DE2732437C3 (de) | Wasserunlösliches Haptoglobinpräparat und Verfahren zu seiner Herstellung | |
| DE4001661A1 (de) | Verfahren und vorrichtung fuer einen bioreaktor mit spezifischer affinitaet und verbessertem transport | |
| EP1256380B1 (de) | Adsorbentien zur Perfusion von Blut und deren Herstellungsverfahren | |
| DE10025964A1 (de) | Katalysatorsystem und seine Verwendung | |
| DE2242710A1 (de) | Komplex eines biologisch aktiven proteins mit einem polymeren | |
| DE2061009A1 (de) | Verfahren zur Fixierung von Polymeren | |
| EP0008656A2 (de) | Verfahren zur enzymatischen Umsetzung mittels trägergebundener Enzyme | |
| DE1959169A1 (de) | Unloesliches enzymatisch reaktives Material |